283 related articles for article (PubMed ID: 21561462)
21. The genetics of paragangliomas: a review.
Martin TP; Irving RM; Maher ER
Clin Otolaryngol; 2007 Feb; 32(1):7-11. PubMed ID: 17298303
[TBL] [Abstract][Full Text] [Related]
22. Screening of mutations in genes that predispose to hereditary paragangliomas and pheochromocytomas.
Lefebvre S; Borson-Chazot F; Boutry-Kryza N; Wion N; Schillo F; Peix JL; Brunaud L; Finat A; Calender A; Giraud S
Horm Metab Res; 2012 May; 44(5):334-8. PubMed ID: 22517554
[TBL] [Abstract][Full Text] [Related]
23. Germline mutations and genotype-phenotype associations in head and neck paraganglioma patients with negative family history in China.
Zhu WD; Wang ZY; Chai YC; Wang XW; Chen DY; Wu H
Eur J Med Genet; 2015 Sep; 58(9):433-8. PubMed ID: 26096992
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
[TBL] [Abstract][Full Text] [Related]
25. Hereditary paraganglioma due to the SDHD M1I mutation in a second Chinese family: a founder effect?
Lee SC; Chionh SB; Chong SM; Taschner PE
Laryngoscope; 2003 Jun; 113(6):1055-8. PubMed ID: 12782822
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular progress in hereditary paraganglioma.
Baysal BE
J Med Genet; 2008 Nov; 45(11):689-94. PubMed ID: 18978332
[TBL] [Abstract][Full Text] [Related]
27. Novel germline mutations in the SDHB and SDHD genes in Japanese pheochromocytomas.
Isobe K; Minowada S; Tatsuno I; Suzukawa K; Nissato S; Nanmoku T; Hara H; Yashiro T; Kawakami Y; Takekoshi K
Horm Res; 2007; 68(2):68-71. PubMed ID: 17308434
[TBL] [Abstract][Full Text] [Related]
28. Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X.
Simi L; Sestini R; Ferruzzi P; Gaglianò MS; Gensini F; Mascalchi M; Guerrini L; Pratesi C; Pinzani P; Nesi G; Ercolino T; Genuardi M; Mannelli M
J Med Genet; 2005 Aug; 42(8):e52. PubMed ID: 16061558
[TBL] [Abstract][Full Text] [Related]
29. The spectrum of SDHD mutations in Russian patients with head and neck paraganglioma.
Shulskaya MV; Shadrina MI; Bakilina NA; Zolotova SV; Slominsky PA
Int J Neurosci; 2018 Dec; 128(12):1174-1179. PubMed ID: 30375904
[TBL] [Abstract][Full Text] [Related]
30. Familial paraganglioma syndromes.
Chetty R
J Clin Pathol; 2010 Jun; 63(6):488-91. PubMed ID: 20498024
[TBL] [Abstract][Full Text] [Related]
31. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.
Baysal BE; Willett-Brozick JE; Lawrence EC; Drovdlic CM; Savul SA; McLeod DR; Yee HA; Brackmann DE; Slattery WH; Myers EN; Ferrell RE; Rubinstein WS
J Med Genet; 2002 Mar; 39(3):178-83. PubMed ID: 11897817
[TBL] [Abstract][Full Text] [Related]
33. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
Burnichon N; Rohmer V; Amar L; Herman P; Leboulleux S; Darrouzet V; Niccoli P; Gaillard D; Chabrier G; Chabolle F; Coupier I; Thieblot P; Lecomte P; Bertherat J; Wion-Barbot N; Murat A; Venisse A; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP;
J Clin Endocrinol Metab; 2009 Aug; 94(8):2817-27. PubMed ID: 19454582
[TBL] [Abstract][Full Text] [Related]
34. Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.
Ricketts CJ; Forman JR; Rattenberry E; Bradshaw N; Lalloo F; Izatt L; Cole TR; Armstrong R; Kumar VK; Morrison PJ; Atkinson AB; Douglas F; Ball SG; Cook J; Srirangalingam U; Killick P; Kirby G; Aylwin S; Woodward ER; Evans DG; Hodgson SV; Murday V; Chew SL; Connell JM; Blundell TL; Macdonald F; Maher ER
Hum Mutat; 2010 Jan; 31(1):41-51. PubMed ID: 19802898
[TBL] [Abstract][Full Text] [Related]
35. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
36. A novel mutation in the SDHD gene in a family with inherited paragangliomas--implications of genetic diagnosis for follow up and treatment.
Renard L; Godfraind C; Boon LM; Vikkula M
Head Neck; 2003 Feb; 25(2):146-51. PubMed ID: 12509798
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.
Jafri M; Whitworth J; Rattenberry E; Vialard L; Kilby G; Kumar AV; Izatt L; Lalloo F; Brennan P; Cook J; Morrison PJ; Canham N; Armstrong R; Brewer C; Tomkins S; Donaldson A; Barwell J; Cole TR; Atkinson AB; Aylwin S; Ball SG; Srirangalingam U; Chew SL; Evans DG; Hodgson SV; Irving R; Woodward E; Macdonald F; Maher ER
Clin Endocrinol (Oxf); 2013 Jun; 78(6):898-906. PubMed ID: 23072324
[TBL] [Abstract][Full Text] [Related]
38. Is the c.3G>C mutation in the succinate dehydrogenase subunit D (SDHD) gene due to a founder effect in Chinese head and neck paraganglioma patients?
Zha Y; Chen XM; Lam CW; Lee SC; Tong SF; Gao ZQ
Laryngoscope; 2011 Aug; 121(8):1760-4. PubMed ID: 21792967
[TBL] [Abstract][Full Text] [Related]
39. Active succinate dehydrogenase (SDH) and lack of SDHD mutations in sporadic paragangliomas.
Braun S; Riemann K; Kupka S; Leistenschneider P; Sotlar K; Schmid H; Blin N
Anticancer Res; 2005; 25(4):2809-14. PubMed ID: 16080530
[TBL] [Abstract][Full Text] [Related]
40. Paraganglioma syndrome: SDHB, SDHC, and SDHD mutations in head and neck paragangliomas.
Schiavi F; Savvoukidis T; Trabalzini F; Grego F; Piazza M; Amistà P; Demattè S; Del Piano A; Cecchini ME; Erlic Z; De Lazzari P; Mantero F; Opocher G
Ann N Y Acad Sci; 2006 Aug; 1073():190-7. PubMed ID: 17102086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
